SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004597
Filing Date
2022-02-10
Accepted
2022-02-10 16:05:39
Documents
12
Period of Report
2022-02-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20220204.htm   iXBRL 8-K 35164
  Complete submission text file 0001564590-22-004597.txt   167503

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220204.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220204_lab.xml EX-101.LAB 20169
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220204_pre.xml EX-101.PRE 12037
6 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20220204_htm.xml XML 3678
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 22613889
SIC: 2834 Pharmaceutical Preparations